EXAS
EXACT Sciences Corporation
Mentions (24Hr)
-100.00% Today
Reddit Posts
The Unprecedented Rise of POOPH Pet Odor Eliminator and the Investment Potential of BioLargo (BLGO)
**BioLargo: The Rising Star in CleanTech with Blockbuster Success POOPH, Exciting Subsidiaries, and Game-Changing Developments**
WHY EPS (basic? simple as net income/shares outs) values calculated very different in inv. recources?
Exact Sciences Announces Blockbuster Q1 2023 Earnings
Exact Sciences Announces Blockbuster Q1 2023 Earnings
MYNZ Multiple Near Term Catalysts Ahead - $50-$75 stock trading at $6/share
MYNZ Multiple Catalysts Ahead $50-$75 stock at $6/share
EPA Proposes Rule to Limit Forever Chemicals in Drinking Water BioLargo DD $BLGO - is Clean Water!! Clean Air, Cleaner Earth, and Much More. #PFAS
Exact Sciences slips despite Q4 beat after in-line outlook (NASDAQ:EXAS)
EXAS stock slips as Credit Suisse downgrades despite Q4 beat (NASDAQ:EXAS)
Cathie Wood of ARK Invest bought 74,862 shares of Tesla today worth around around $11.7 million
Cathie Wood of ARK Invest bought 74,862 shares of Tesla today worth around around $11.7 million
Introduction to Clean Tech BioLargo - Already UP 40% in the past month. $BLGO will get discovered.
BioLargo DD 2022 $BLGO - is Clean Water!! Clean Air, Cleaner Earth, and Much More.
Renalytix (RNLX) - An undervalued gem in AI diagnostics for kidney disease and a potential multi-bagger
BUY EXAS NOW - clinical data means rocket to $500+
Exact Sciences (EXAS) is about to take off
Exact Sciences (EXAS) Approached Invitae (NVTA) For Merger Offer
If you rearrange the letters in NIO you get...
Sh1t in a box! #EXAS Can you really poop in a box to prevent cancer? This company has does it. At-Home Colon Cancer Screening | Cologuard® Patient Site
Literally a DD on investing in a shit in the box and why it will make you tendies. (EXAS)
$EXAS looks like a green light to me but I’m young at this game and want some outside opinions.
[$PAVM] PAVmed: Breakthrough Pre-Esophageal Cancer Detection Device - Expecting >3x Growth as Revenue Scales
Mentions
I am 95 % in BioLargo. Shifted massive gains between 1200%- 2500% from $exas to $BLGO Accumulated 1.25% of a penny stock company that has yet to explode to the upside. Anything below 20x returns would be a disappointment. But for now an index fund would have been a better investment - but that was the case as well with EXAS - for years - before that started running. BLGO lift off seems very close and with such a commitment it could become life changing gains. Still hold 400 EXaS shares with $5 average.
XBI exposure, when the news of pharma tariffs happened, sold a bunch of puts, which turned into 15k gains. Then used that to buy picks and shovels and some specific names. Now I have XBI, IQV, ICLR, REGN, BIO, BRKR, AVTR, EXAS, ILMN, also many big biotech.
Awesome to hear you’re looking closer at BioLargo — I honestly think the deeper you dig, the more you’ll like what you find. Right now they’ve got about $3.5M cash on hand, and they’ve been pretty disciplined with their overhead. Exec comp isn’t a big drag on the burn rate either — most of management are already the largest shareholders, and a lot of their pay is in stock/options (CFO literally only gets paid in stock). That’s real skin in the game. On dilution: you’re right, they’ve leaned on it in the past, but the pace of new issuance has dropped YOY. In preparation of the Clyra launch they had to invest more. The real “end of dilution” will come from execution — and they’re lining up real-world deployments in PFAS cleanup, odor control, energy storage, water treatment, and the focus of the post above - healthcare (wound care). Each of these is a huge market on its own, so if any one of them scales, the financing picture changes a lot. Politics/renewables: yeah, headlines can shift sentiment short-term, but BioLargo’s value is less about chasing subsidies and more about solving trillion-dollar problems. People are always going to need safe water, PFAS-free systems, better batteries, better wound care. These demand drivers don’t go away with the election cycle. And about the spike last year — yeah, that was a crazy ride. At the peak, I was nearly $1M up on paper. But honestly, I didn’t get into this for a quick flip. I’m in it until the full story unfolds. That mindset makes it easier to sit tight through the chop, because I know I’m backing something that can actually make a difference. Like Munger said: “the big money is in the waiting.” That’s been true for me before (EXAS was one I held long before the market caught on), and I’m applying the same patience here. Current price? I don’t see it as discouraging — I see it as a gift. More time to accumulate before the crowd wakes up. And yeah, we’ve got a strong little shareholder community around this. A lot of folks ended up with big positions after doing the deep dive themselves - and we talk BLGO 24/7 - it is great community. It would be great to have you become a part of this!! Please let me know if you have more questions.
**My Perspective on Opportunity Cost and Investment Strategy **When it comes to investments, each of us brings a unique perspective and approach. I want to share my personal journey to illustrate the power of patience, research, and conviction in pursuing high-reward opportunities. A Lesson from Experience Years ago, I chose to invest in a company with a clear and noble mission: the eradication of cancer. That company was Exact Sciences (EXAS). Many investors grew impatient when the stock went through dormant and even declining phases. However, I committed to intensive daily due diligence and trusted the strength of my own research. Instead of chasing quick wins elsewhere, I continued to build my position—averaging down significantly during periods of market pessimism and doubt. While others were tempted to cut their losses or seek opportunities with seemingly more promise, I stayed focused, guided by the underlying progress that was unfolding. The result? While some may have made modest gains elsewhere or ultimately sold at a loss, I realized between 1,650% and 2,500% gains—returns made possible by conviction and discipline over short-term noise. Applying the Lesson to BioLargo I directed those substantial gains directly into BioLargo Five of my six accounts are currently showing profits. Although some investors are starting to feel impatient or searching for new opportunities, I consider this stage a valuable advantage. Whenever I find a chance similar to what I experienced with EXAS, I’m ready to fully commit. That’s exactly the approach I’m applying to BioLargo. My Conviction in BioLargo • Unwavering Confidence: I have zero doubt that BioLargo will multiply in value. To me, it’s not a question of “if,” but “when.” • Unique Position Among OTC Companies: While many over-the-counter (OTC) companies have lost value, BioLargo has remained stable for an extended period. The progress behind the scenes is impressive, and I firmly believe the share price will eventually reflect this. • Personal Stake: I am proud to say that I own 1.25% of the company. Closing Thoughts Opportunity cost is real, and so is the temptation to jump from one high-potential idea to the next. My experience has shown that true conviction, supported by rigorous research and patience, can yield life-changing results. I see in BioLargo the same rare combination of purpose, progress, and potential. I’m here for the long game, and for me, the real opportunity is right in front of us.
This chart looks almost exactly like mine, except 4 years ago I only made it to ~$100 profit before I never saw it again. I was down over 32%. Now I’m only down 2%. I’m almost there. $ASTS and $EXAS need to show some more love
Holy fuck man I sold a 55c for today on EXAS, the universe hates me this week I guess.
If Exact Science $EXAS moons, I’ll finally break even. 🤞
EXAS and GH will loose their positions... recent Armistice fund filling shows trust on this one 222k shares @ $6.77 which is roughly $1.5M. Do they know something that we don't? https://preview.redd.it/e76hblquwnte1.png?width=619&format=png&auto=webp&s=c084a7bcc8d3c35a276043faf55137127d7ae13c
I made 20X returns with EXAS that has the ColoGuard product and eradicating Cancer on their flags. So I think it is great to invest into something purposeful, the cancer treatment field is tough though. How do they finance themselves?
TTD and AXON ... Maybe some EXAS too ... And maybe PZZA
Bro if someone saw my portfolio as a beginner investor, yall would say im nuts. I started investing, and went full port 130k into nvidia earningsc an lost like 30k. I then made back all the way to 160k, and then bet on DJT and EXAS sciences and went all the way back down to 90k Then came back from MSTR, all the way back to 165k. And now, through betting on some horrible stocks, I am back at 100k. Like wtf. This shouldn’t have happened. What am I doing. I’m exhausted. Should I just take a break? I’m never gonna continuous make money.
What makes the product any better than Colonguard? Their ticker is EXAS is at $59/share with 250m+ negative revenue so I realize this market makes zero sense to me.
I bought heavily into EXAS when It was trading around $5. I was averaging down, but believed in their story. https://preview.redd.it/2hoqnx53hz4e1.jpeg?width=1290&format=pjpg&auto=webp&s=fc8988020339bb5d74759a85eae3cb3b3ef5a538 Then it became a 20X plus return. Broke the $100 mark. Sold some around 2000% gains and some at around 30X ($145 ish) and shifted most to BLGO that I am proud owning more than one percent of now because of those gains ;) My 400 remaining Exas shares are still at above 1000% gains. But certainly sold most (90%) at the right time for almost $ 1/2 Million gains. Pure luck! It’s a waiting game. Patience is always key for investing. That is why I only invest in very purposeful companies - it is Ok if the stock does not move for a while or dips if my money is helping to work on the eradication of cancer (EXAS) or if the company works on solving some of the biggest environmental and wound infection challenges (BLGO) .
I bought heavily into EXAS when It. was trading around $5. Actually the CEO did a 50k shares insider buy on the open market to show his confidence. Then it became a 20X plus return. Sold some at 30X and shifted most to BLGO that I am proud owning more than one percent of the company. I expect even higher returns there ;) It’s a waiting game. Patience is always key for investing.
I was going to say EXAS (20 bagger with 5000 shares) but now I’m scared my wife might read my post! She’s definitely a keeper! Prepaid college tuition (state plan) for both daughters was a great one as well!
Thanks for your list for today. I had $EXAS on my list but it doesn’t have a lot of volume today.
EXAS sciences and DJT. I’ve been depressed
why I didn’t buy put on EXAS  why 🤡
Anyone else buy EXAS puts or just me
I’m just catching fat L’s left and right today. Got myself into EXAS before market close. Down 30% after ER
Bought calls for LPX and EXAS. Liked the price for both of them and they shot up pretty well. After market looks good for both too. I think LPX won't trend bearish anymore and expect it to explode when market opens. They've done well previous earnings despite market instability and they have a promising side ventures as they try to be more cash stable (they've reported more cash flow). I think with good guidance the stock moves up 10 percent.
>…something big is happening with it. >Thoughts? [Here](https://s22.q4cdn.com/877809405/files/doc_financials/2024/q2/2Q24-EXAS-presentation.pdf) is their 2Q24 earnings presentation, maybe read it and understand their business a bit before saying “something big is happening with it” without even saying why you believe that.
I’m concerned about $MYNZ’s ability to compete with established players like EXAS and GH. They’ve got proven products and market presence, while Mainz is still trying to get off the ground.
I’m concerned about $MYNZ’s ability to compete with established players like EXAS and GH. They’ve got proven products and market presence, while Mainz is still trying to get off the ground.
You're right; established players like Exact Sciences (EXAS) and Guardant Health (GH) have FDA-approved products. However, the growing demand for cancer diagnostics leaves room for new entrants like Mainz Biomed ($MYNZ). If they can differentiate and secure partnerships, they might find their niche.
Aren't there already several big players in the market with Fda approved products? Off the top of my head, EXAS and GH have products on market already.
Oooooh buddy… Of the top of the dome. I’m going with HOOD, PYPL, NVAX, DLO, OKLO, GCT, WULF, DDOG, EXAS. I think out of all the crypto mining companies that also have technology catering to AI is going to be the next big most “for sure” bet. I’ve been following BTC for too long, seen it go through too many black swan events and just continue to stay super bullish. Go look at the chart on the monthly time frame.
#Did you win…… oh, I’ll give you your privacy. The amygdala is your worst enemy. Also EXAS… beep beep beep
You guys don’t like EXAS? Downvoters have to buy 190 🌈🪑
**Well well, look what $EXAS dragged in from the ‘hood.** **Looks like a little break out… pt to 56 and a dinger gap fill to 63 Dollar Street, Your Town, USA.** **Book it.** #i am wrong a lot too though, frfr
What are your thoughts, if any, on EXAS? Been beaten WAY down for a long time - similar "no colonoscopy" cancer screening.
I am a longterm Investor. I would be disappointed if I would make less returns than on EXAS. Currently they are around .25 - around $75 Million market cap and I think it won’t take too long until this will be a $250 Million company with the potential to be a few $ in a couple of years.
If I say EXAS, please don't hate me... thinking 3-5 yrs and fcf in the near future...
As of rn, I don’t have much history on stocks because I’m focused on green companies. Here’s what I look at: 1. Company’s plans, history, markets. Where are they, and how much they invest in growth. 2. Who are their competitors, how did they start, where is their stock now? 3. Does anyone know about them? Is there a buzz on socials? 4. Are there any news, changes in legislation, etc. that can impact the company’s position for the next 3-6months. This is how I found my diamonds, $MYNZ and $LOBO. Will be grateful for your opinions and brrakdowns of my thought process. The first one is early cancer detection, straight out of Germany. Now trades at $0.4. Their competitor $EXAS is a lot smaller in volume and quality is lower, but trades at $40. All that’s missing for MYNZ is the FDA approval. And the gears will start rolling. The second one, $LOBO, is a trickier one. Chinese company, makes e-bikes and scooters. Started growing massively into SA markets, invested all money from IPO into growth. Now at $2.8, but Zacks Small Cap set a $5 price target on them. Again, the only thing missing for a huge boost is their US presence. I’m hoping that a new tax rebate on e-bikes will fix that pretty fast.
Thoughts on EXAS for growth potential?
Anyone else looking at $KVUE and $EXAS earnings this week?
EXAS. Bought 20k worth at 9 bucks a share and sold at $23
Every day I just hope for my shitty $U and $EXAS bags to go up but they never do. Might just cut the losses and throw them both in MSFT at this point
ROKU cucking me rn. At least my EXAS position is looking decent before earnings later
EXAS for earnings next week
That’s my oldest holding too! Purchased in 2009 when I first started out. I also sold some when I needed money when younger (school, housing.) But I still have some in my Roth and it’s up ~2200%, always makes me smile. I have always set out to purchase companies and never sell unless the investment thesis is broken. Looking at the chart for $EXAS, it’s clear why that works and that I’d never would have been able to time it.
EXAS Bought 700 at $6.00 during a low in 2016, now trades in the high $50 to low $60s range but I sold most of it at around $119 I still hold 200 shares for nostalgia
EXAS for earnings next week
I used to read the IBD newsprint and found PODD when it was selling for $10. To me it was a no brainer. I was new to investing and wasn’t patient enough to sit on it. Sold for a small gain only to see it blow up into the 100’s. Lesson learned. I found IBD very helpful in finding low priced stocks with potential but you have to weed through a lot of low priced stockes to find one you believe is worth risking it. And then use common sense. When I saw an early commercial for EXAS cologaurd jumped out at me. I knew people wanted an excuse not to have to go through the night before prep for a colonoscopy and have to take a day off work for it. It was selling for around $15. I watched it and finally bought in at $30. It put my kids through college. It’s still on my watch list. Another thing I did was watch some local companies and find their trading patterns over the coarse of a few years and from there find an entry point you like and then take some modest profits. starting out I’d say check out IBD.
My dad bet on the horses & the dogs. He did quite well on betting trifectas. Idk how he did it. So amazing when he hit big. He never put us in the poor house. I really picked a winner with EXAS exact sciences I bought at $30 and sold at $95… that was nice. Now I set the alerts for below $45 so I can watch it closely when it drops next time. Then jump in and wait.
Wise men of wsb, I once bought PLTR and EXAS and now I might want to sell (both -35%). But just one of them or both?
I learned not to think that way as a purpose driven long term investor. What you mention is a different strategy that works well for many. Not for me. I am going to find opportunities that could give 20X returns. By nature those might underperform the market. With EXAS I was in the red for 2 years and then it went up 2300%. That taught me to believe in my own DD and see the price fluctuation s as noise or opportunity. I bought as much as I can afford to hold. Because the POOPH revenues are guaranteeing that I can’t lose at all - but might win the cleantech jackpot. What is not to like?!?
The one thing I am anticipating is her DD on the valuation for my DNA. They said one was forthcoming. When Tesla was shitting the bed and early days she made a convincing argument that changed things for Tesla, to a certain extent. Then, more recently, she released one on $EXAS and it created a big pump. https://ark-invest.com/articles/valuation-models/ark-exact-sciences-model-2027/ C’mon Cathie, I know you have the goods. 🤡😂🔥release the kraken.
We're you with EXAS before or after the TARDIS and Ashion transactions?
My only alignment with the company is as a shareholder since 2016. The only information I have access to is from public sources, including company investor presentations. If, as you say, you were in charge of the MRD program at EXAS I would be very interested in your perspective, although it is quite apparent you did not leave on good terms. I am sure there may be some truth in what you say. If EXAS had developed a commercially viable MRD test themselves, they likely would not have licensed the MAESTRO technology: Exact Sciences and Broad Institute have entered into a 5-year sponsored research agreement and an exclusive license agreement to utilize Minor Allele Enriched Sequencing Through Recognition Oligonucleotides (MAESTRO) as its molecular residual disease diagnostic testing platform. MAESTRO is a next-generation circulating tumor DNA technology that can detect thousands of patient-specific mutations using minimal sequencing and advanced bioinformatics, creating a scalable test platform for enhanced detection of molecular residual disease. The Broad Institute is globally recognized for leading innovations in the field of genomics and next-generation sequencing methodology. MAESTRO was developed at the Broad Institute's Gerstner Center for Cancer Diagnostics which is focused on breakthrough innovations for significant unmet needs in cancer diagnostics. Why was EXAS, under your leadership, unable to develop its own MRD test?
EXAS is a scam, IMO. their tests almost always come back Pos... so that the Gastro-Docs can cash in on $3000 colonoscopies... which is why they recommend them to patients that refuse colonoscopies in the first place. I got a pos from Cologuard 6-7 years ago... then they did a 2 sample test... I called them to ask which sample came in Pos... they refused to tell me... I said WHAT?? OK, send the specific results to my doctor... again... refused. Like I said, a scam run by dirtbags. The Pinnacle FIT test (do at home) is great... I have done one every 6 months since the Cologuard FUBAR... all came in negative... of course.
It can work out. Or it can't. I'll give two examples. 12 years ago I bought a bunch of EXAS. Exact Sciences. Was something like $4 a share I think. I bought it because I saw my boy Jim Crammer talking about it on Mad money, lol. They make the do it at home colan cancer test. You poop in a box and send it to them. They aren't making a profit yet, but they have traction and the stock is at $85 now. (Its been to $125, but it moves a lot). That company has been great for me, and I think they will be profitable sometime. People are using the test all over. A couple years ago I bought CRSP. Crispr. The gene editing thing. I think it has huge potential. Could end up curing cancer or aids. I bought it at the near high though, around $125. Its now $50. I'm holding though because it could be a giant profit. But it has massive risk IMO. If the republicans take over the white house/senate/congress with large majorities I think they will outlaw it 100%. Just because it would be blasphemous. Can't edit the genes in the body, that would go against their core beliefs of being made in the image of a god. Ten years ago I would have said there was no chance they would do that, but now I totally think they would. But its worth the risk to me. I wouldn't stack my portfollio with companies like those. But I don't mind 10-15% of my holdings being risky bets. Sometimes they pay off. But only for companies that I can see how they would be profitable. I wouldn't invest in some crazy company that I thought was stupid.
AI, PLTR, EXAS, SHOP, CRWD, MFST, AAPL, META companies that either explicitly operate in that space, or are adopting a lot of AI in their products. Manufacturing is also on the rise so I'm buying a lot of stocks like X, nue, the current administration is investing a lot in infrastructure, so that should help increase demand for companies that provide steel. AMAT is the stock I like in particular
AI, PLTR, EXAS, SHOP, CRWD, companies that either explicitly operate in that space, or or adopting a lot of AI in their products
I rode EXAS all the way down and back up from 2021 to now, and sold a few weeks ago at $90. Kind of regret it already, could be a good long term play
bought EXAS at 14, then it dropped to 7 and i tripled down. still holding a decade or so later. hoping for it to skyrocket even more.
EXAS. Beat and raise yesterday and down 12% today.
Follow on note, the goal trajectory is something like that of EXAS, which proved that a serum test + AI algorithms have higher accuracy and cost effectiveness than a legacy surgical evaluation. Becoming the new standard of care in this way creates very large market potential.
My portfolio is all out of wack because of this phenomenon. I pour money into high conviction plays because I want the positions to be large enough that if I hit, it means something. Because of this, 80% of my portfolio is five tickers (after some nice runs). And I’m not rebalancing, I’m adding because shit is just heating up. Concentration is not the enemy with this type of bet. Honestly, if I had what you did I’d be betting 2 or 300k on the wacky shit (since you call things like EXAS “moonshot”) to try to hit some grand slams. You have plenty of safe shit to fall back on. Think of best case scenario where you 5x your 20k — with so little capital deployed, you’ve won the war but gotten zilch for spoils. I’d def suggest more risk.
Now she’s all about Exact Sciences ($EXAS). Hopefully AI can revolutionize cancer diagnostics.
Another undervalued sector that will greatly benefit from AI is genomics. Think EXAS, CRSP, DNA, TDOC. Massive data sets + AI to sift through these data sets = profit? probably maybe.
Cathie Wood's ARK active ETFs bought 233K shares of ROKU and 163K shares of HOOD. Conversely, the firm sold 379K shares of SHOP and 81K shares of EXAS
Cathie Wood's ARK active ETFs bought 160K shares of TSLA and 53K shares of BEAM. Conversely, the firm sold 287K shares of SHOP and 177K shares of EXAS
Cathie Wood's ARK active ETFs bought 101K shares of COIN and 168K shares of U. Conversely, the firm sold 215K shares of EXAS and 23K shares of TSLA
EXAS, ZIM and MU puts are making a little bit. SPY and LULU puts are not.
sold the last of my CTAS calls today for a tidy profit. I'm mostly cash now and will prob stay for a bit. I do have a few puts on GME, ZIM and thanks to a recommendation last night, EXAS.
EXAS is the number 2 overall holdings across all ark funds. cathie has been heavily selling shares since the start of this year yet still owns a 5.81% of the company. my guess is the selling was mainly because at peak, ark owned over 8% of the company. cut to the chase: puts on exas
About the OP: I am a purpose-driven filmmaker and investor that has made amazing returns on my Exact Sciences investment - my core position was up between 1600% and 2650 % when I sold most and placed it into BioLargo - where I expect even higher returns. Don't judge me that I made a lot of money with POOP in a box - Cologuard cancer screening and I am about to make much more with POOPH Pet odor elimination. I swear it is by coincidence ;) For many years I was sharing all the info I could find about EXAS and paired it with my thoughts on the Yahoo message board. I promised myself that whenever I’ll feel 100% confident again that I found a "guaranteed" multi-bagger - I will bet the farm.
Cathie Wood's ARK active ETFs bought 299K shares of COIN and 1.82M shares of DNA. Conversely, the firm sold 242K shares of EXAS and 191K shares of TWLO
Cathie Wood's ARK active ETFs bought 47K shares of TSLA and 160K shares of HOOD. Conversely, the firm sold 228K shares of EXAS and 56K shares of MNDY
EXAS about to moon AH when they report profitable a quarter earlier than expected
Many people have been selling EXAS and taking profits before earnings to hedge or get out safe including myself. I have done technical analysis and there is a good chance they will beat earnings and provide positive guidance moving forward. I sold 75% of my shares and bought calls either way I win
Cathie Wood's ARK active ETFs bought 3K shares of TRMB and 15K shares of KTOS. Conversely, the firm sold 17K shares of EXAS and 22K shares of PRLB
Looks like she timed EXAS PERFECTLY
Cathie Wood's ARK active ETFs bought 22K shares of TSLA and 50K shares of EXAS. Conversely, the firm sold 3K shares of MNDY and 1K shares of NVDA
she is at it again...Cathie Wood's ARK active ETFs bought 112K shares of EXAS and 26K shares of TSLA. Conversely, the firm sold 21K shares of MTLS and 7K shares of ONVO
>EXAS is a great company and their Cologuard test is definitely one of the best ways to catch cancer early. I believe that they have a lot of potential to grow in the future and make their investors a lot of money.
**User Report**| | | | :--|:--|:--|:-- **Total Submissions**|0|**First Seen In WSB**|just now **Total Comments**|0|**Previous Best DD**| **Account Age**|1 year|[^scan ^comment ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_comment&message=Replace%20this%20text%20with%20a%20comment%20ID%20(which%20looks%20like%20h26cq3k\)%20to%20have%20the%20bot%20scan%20your%20comment%20and%20correct%20your%20first%20seen%20date.)|[^scan ^submission ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_submission&message=Replace%20this%20text%20with%20a%20submission%20ID%20(which%20looks%20like%20h26cq3k\)%20to%20have%20the%20bot%20scan%20your%20submission%20and%20correct%20your%20first%20seen%20date.) ^^[**Discord**](http://discord.gg/wsbverse) ^^[BanBets](https://www.reddit.com/r/wallstreetbets/wiki/banbets/) ^^VoteBot ^^[FAQ](https://www.reddit.com/r/wallstreetbets/wiki/votebot/) ^^[Leaderboard](https://www.reddit.com/r/wallstreetbets/wiki/leaderboard/) ^^- ^^[**Keep_VM_Alive**](https://www.patreon.com/visualmod) >TL;DR: EXAS is a company that makes tests to detect cancer early. They're a real lifesaver and their stock is a no-brainer, it's going to go up and make you some serious dough. Don't miss out on this opportunity, invest in EXAS today and watch your money grow.
I don’t invest emotionally but if you mean some of my biggest winners. I’m a contrarian investor, an intellectual speculator, if you will. Kite Pharma was bought out by Gilead Sciences handing a 226% gain in 13 months. MyoKardia was bought out by Squibb and I booked a 331% profit. Proof point(PFPT) 129% in two years. EXAS I’m up 100% so far and there is still plenty of meat on the bone. These are just the ten baggers. Too many to list.
EXAS, CRSP, ARKG. 2023 year of genomics
Based off results last quarter EXAS is about to be profitable again